Skip to main content

What the FDA labels say about taking them together

Bosentan and etonogestrel

Etonogestrel's FDA label of May 28, 2026 names bosentan in its drug interactions section; the bosentan label PlainMeds reads does not name etonogestrel. The etonogestrel label: “Some drugs or herbal products that may decrease the effectiveness of HCs include efavirenz, phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, topiramate, rifabutin …”

Check it at the source: the bosentan FDA label on DailyMed (effective November 17, 2025, Actelion Pharmaceuticals US, Inc.); the etonogestrel FDA label on DailyMed (effective May 28, 2026, Organon LLC).

What does the bosentan label say about etonogestrel?

Bosentan's label (effective November 17, 2025) does not name etonogestrel in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tracleer), Actelion Pharmaceuticals US, Inc., effective November 17, 2025 (SPL set 749e42fb-2fe0-45dd-9268-b43bb3f4081c), via openFDA; the full label on DailyMed

What does the etonogestrel label say about bosentan?

Etonogestrel label, drug interactions

Some drugs or herbal products that may decrease the effectiveness of HCs include efavirenz, phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, topiramate, rifabutin, rufinamide, aprepitant, and products containing St. John's wort.

Source: FDA drug label (Nexplanon), Organon LLC, effective May 28, 2026 (SPL set 487f8a62-e142-457c-97cc-2e398fde7594), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Bosentan generic labelers
0Etonogestrel generic labelers
BosentanEtonogestrel
Labeled forPulmonary arterial hypertensionBirth control
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?